Paid Clinical Trials in Flint, MI
As of July 2026, 144 paid clinical trials are recruiting in Flint, Michigan. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Flint offers studies at sites including Genesys Hurley Cancer Institute for conditions such as Stage IV Lung Cancer AJCC v8, Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Flint
Trials by drug in Flint
Filter results
Newly added in Flint
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
138 clinical trials
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Pelacarsen Roll-over Extension Program
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
C-Brace Prospective Registry
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Family Communications After Genetic Testing
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Top Research Study Locations in Flint
Researchers run research studies in Flint, MI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Genesys Hurley Cancer Institute | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 71 |
| Hurley Medical Center | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 61 |
| Cancer Hematology Centers - Flint | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 59 |
| Genesee Hematology Oncology PC | Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, Cancer | 29 |
| McLaren Cancer Institute-Flint | Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Metastatic Malignant Neoplasm in the Brain | 14 |
| Karmanos Cancer Institute at McLaren Flint | Advanced Solid Tumor, Breast Cancer Stage I, Breast Cancer Stage II | 6 |
| Genesee Cancer and Blood Disease Treatment Center | Anatomic Stage IV Breast Cancer AJCC v8, Cancer, Castration-Resistant Prostate Carcinoma | 5 |
| AA Medical Research Center | Aortic Stenosis, Cardiovascular Disease and Lipoprotein(a), Moderate to Severe Chronic Obstructive Pulmonary Disease | 4 |
| Aa Mrc Llc | Atherosclerotic Cardiovascular Disease (ASCVD), Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 4 |
| McLaren Proton Therapy Center | Breast Cancer, Breast Neoplasm, Breast Tumor | 4 |
| Michigan State University | Colorectal Cancer, Health Disparities, Maternal Morbidity and Mortality | 3 |
| AA Medical Research Center (MRC) | Atrial Fibrillation (AF) | 2 |
| AA MRC LLC Ahmed Arif Medical Research Center | Systemic Lupus Erythematosus (SLE) | 1 |
| Aa Mrc Mhs | Atherosclerotic Cardiovascular Disease | 1 |
| Ahmed Arif Medical Research Center (AA MRC LLC ) | Atherosclerosis | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Corazon Imaging | Atherosclerosis, Cardiovascular Inflammation, Coronary Artery Disease | 1 |
| Dermatology & Cosmetic Center PLLC - Flint | Pyoderma Gangrenosum | 1 |
| Dermatology and Cosmetic Center | NonSegmental Vitiligo | 1 |
| Elite Clinical Research Center | Hypothyroidism | 1 |
| Elite Research Center | Type 1 Diabetes Mellitus With Hypoglycemia | 1 |
| Elite Research Center, LLC | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| Flint Development Center | Cardiovascular Health, Health Promotion | 1 |
| Flint Journal Building | HPV Vaccination | 1 |
| Flushing Road Internal Medicine and Pediatrics - F | Chronic Obstructive Pulmonary Disease | 1 |
Active & Upcoming Studies in Flint (2026)
Recruiting trials in Flint grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (82 active studies)
- A Study of the TheraBionic P1 Device in Breast Cancer · Barbara Ann Karmanos Cancer Institute
- Family Communications After Genetic Testing · Alliance for Clinical Trials in Oncology
Cardiovascular (9 active studies)
- Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable · Phase 3 · Regeneron Pharmaceuticals
- CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA) · Corazon Medical PC
Diabetes & metabolic (3 active studies)
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity · Phase 3 · Pfizer
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Mental health & behavior (2 active studies)
- The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention · Michigan State University
- Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers · University of Michigan
Neurology & pain (2 active studies)
- REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry) · Medtronic Neurovascular Clinical Affairs
- Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial · Phase 3 · Mercy Health Ohio
Eye & vision (1 active study)
- Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2 · University of Michigan
Common conditions studied in Flint
- Stage IV Lung Cancer AJCC v8 (7 active studies)
- Acute Myeloid Leukemia (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Anatomic Stage IV Breast Cancer AJCC v8 (4 active studies)
- Lung Non-Small Cell Carcinoma (4 active studies)
- Recurrent Lung Non-Small Cell Carcinoma (4 active studies)
Leading research sponsors in Flint
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- SWOG Cancer Research Network
- NRG Oncology
- ECOG-ACRIN Cancer Research Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Flint?
There are approximately 144 recruiting clinical trials in Flint, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Flint pay participants?
Most recruiting trials in Flint compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Flint?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Flint?
The most common conditions under active study in Flint include Stage IV Lung Cancer AJCC v8 (7), Acute Myeloid Leukemia (6), Anatomic Stage II Breast Cancer AJCC v8 (4), Anatomic Stage IV Breast Cancer AJCC v8 (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Flint?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Flint on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Flint?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Flint?
Recruiting research sites in Flint include Genesys Hurley Cancer Institute, Hurley Medical Center, Cancer Hematology Centers - Flint, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Flint right now?
The largest active categories in Flint are Cancer & tumors (82), Cardiovascular (9), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.